Wuhan East Lake High Technology Group Company
Wuhan East Lake High Technology Group Co., Ltd. is a China-based company that specializes in engineering construction, environmental protection technology, and the development of technology parks. Established in 1993 and headquartered in Wuhan, the company undertakes various infrastructure projects, including the construction and maintenance of highways, large bridges, and municipal facilities. In addition to its engineering services, Wuhan East Lake High Technology is involved in environmental initiatives, focusing on projects such as flue gas treatment, urban sewage management, lake water purification, ecological restoration, and solid waste treatment. The company also plays a significant role in the investment, development, and operation of technology parks, thereby contributing to urban development and environmental sustainability.
Top Regions
Top Stages
3 past transactions
Gene Vector
Venture Round in 2025
Chengdu Genevector Biotechnology Co., Ltd. is a biotechnology firm specializing in the research and development of adeno-associated virus (AAV) gene therapy drugs. The company is dedicated to creating innovative therapies targeting a range of medical conditions, including ophthalmic diseases, neuromuscular disorders, hereditary diseases, cardiovascular and cerebrovascular diseases, as well as neurodegenerative diseases. Genevector aims to establish a comprehensive technology chain for AAV drug development, facilitating the delivery of novel biotherapy solutions to address significant health challenges.
Gene Vector
Seed Round in 2022
Chengdu Genevector Biotechnology Co., Ltd. is a biotechnology firm specializing in the research and development of adeno-associated virus (AAV) gene therapy drugs. The company is dedicated to creating innovative therapies targeting a range of medical conditions, including ophthalmic diseases, neuromuscular disorders, hereditary diseases, cardiovascular and cerebrovascular diseases, as well as neurodegenerative diseases. Genevector aims to establish a comprehensive technology chain for AAV drug development, facilitating the delivery of novel biotherapy solutions to address significant health challenges.
Migos Medical
Migos Medical is an innovative medical device company specializing in minimally invasive ophthalmology. Its core technology is based on active cationic polymerization biomaterial technology, which likely enables advanced biomaterials for ophthalmic applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.